Murine monoclonal and rabbit, murine, and human polyclonal antibodies against chlamydial lipopolysaccharide (LPS) were characterized by the passive hemolysis and passive hemolysis inhibition assays and by absorption experiments with LPSs of Chlamydia psittaci, Chlamydia trachomatis, and a recombinant strain of Salmonella minnesota Re (r595-207) expressing the chlamydia-specific LPS epitope, as well as natural and synthetic partial structures of chlamydial LPS. Eleven monoclonal antibodies of the immunoglobulin M and G classes were characterized as chlamydia-specific by their failure to react with Re-type LPS, binding to a similar epitope for which the trisaccharide a-3-deoxy-D-manno-2-octulosonic acid (KDO)-(2-8)-a-KDO-(2-4)-CL-KDO was an absolute prerequisite. For optimal binding, parts of the lipid A moiety were also involved; however, phosphoryl and ester-linked acyl groups and the reducing glucosamine residue of lipid A were dispensable. A similar antibody specificity was detected in lapine and murine hyperimmune sera after immunization with chlamydia, in addition to those recognizing more complex (e.g., those requiring the presence of phosphoryl residues) and less complex epitopes. Among the latter were those cross-reacting with Re-type LPS, which could be removed by absorption. The titers of different antibody specificities, in particular the ratio of chlamydiaspecific to cross-reactive antibodies, present in murine polyclonal antisera depended on the immunization protocol. The preferential formation of chlamydia-specific antibodies was observed after immunization with liposome-incorporated immunogens. Human sera from patients with suspected genital chlamydial infections were also found to contain chlamydia-specific and cross-reactive antibodies, the latter of which could be removed by absorption with Re-type LPS.
Murine monoclonal and rabbit, murine, and human polyclonal antibodies against chlamydial lipopolysaccharide (LPS) were characterized by the passive hemolysis and passive hemolysis inhibition assays and by absorption experiments with LPSs of Chlamydia psittaci, Chlamydia trachomatis, and a recombinant strain of Salmonella minnesota Re (r595-207) expressing the chlamydia-specific LPS epitope, as well as natural and synthetic partial structures of chlamydial LPS. Eleven monoclonal antibodies of the immunoglobulin M and G classes were characterized as chlamydia-specific by their failure to react with Re-type LPS, binding to a similar epitope for which the trisaccharide a-3-deoxy-D-manno-2-octulosonic acid (KDO)-(2-8)-a-KDO-(2-4)-CL-KDO was an absolute prerequisite. For optimal binding, parts of the lipid A moiety were also involved; however, phosphoryl and ester-linked acyl groups and the reducing glucosamine residue of lipid A were dispensable. A similar antibody specificity was detected in lapine and murine hyperimmune sera after immunization with chlamydia, in addition to those recognizing more complex (e.g., those requiring the presence of phosphoryl residues) and less complex epitopes. Among the latter were those cross-reacting with Re-type LPS, which could be removed by absorption. The titers of different antibody specificities, in particular the ratio of chlamydiaspecific to cross-reactive antibodies, present in murine polyclonal antisera depended on the immunization protocol. The preferential formation of chlamydia-specific antibodies was observed after immunization with liposome-incorporated immunogens. Human sera from patients with suspected genital chlamydial infections were also found to contain chlamydia-specific and cross-reactive antibodies, the latter of which could be removed by absorption with Re-type LPS.
Chlamydiae are pathogenic, obligatory intracellular parasites causing a variety of diseases in animals and humans. Little is known about molecular mechanisms of pathogenicity of these unique microorganisms and the host defense mechanisms against them. Surface structures of chlamydiae are involved in the early steps during infection (adhesion and penetration), and these at the same time are surface antigens against which antibodies are raised during infection.
It is known that chlamydiae possess a surface glycolipid antigen which harbors a genus-specific epitope containing an immunodominant sugar chemically related to 3-deoxy-Dmanno-2-octulosonic acid (KDO) (11, 12) . Chemical studies on this antigen have shown that it contains typical chemotaxonomical markers for lipopolysaccharide (LPS), such as KDO, D-glucosamine, phosphorus, and long-chain 3-hydroxy fatty acids (9, 19) . This composition is similar to that of LPS from enterobacterial Re mutants (8) and thus provides a basis to understand cross-reactions between chlamydiae and other bacterial species on the molecular level. Studies on monoclonal antibodies against the Re-type LPS, containing an a-2,4-linked KDO disaccharide in its saccharide portion, have shown that antibodies which recognize the KDO (5) or lipid A region (3) or both (22) Such antibodies also react with chlamydial LPS (1) and are obviously present in polyclonal anti-chlamydia antisera, thus causing their cross-reaction with Re-type LPS. In addition, monoclonal and polyclonal antibodies which recognize the chlamydia-specific LPS epitope and do not cross-react with Re-type LPS have been described (7, 9, 10, 20) .
We found that chlamydial LPS contains a linear KDO trisaccharide of the sequence (x-KDO-(2-8)-a-KDO-(2-4)-KDO, in which the oa-2,8-linked disaccharide portion was assumed to represent the immunodominant region of the genus-specific epitope (1, 16) . In the meantime, we have prepared a variety of synthetic compounds and chemically defined partial structures of LPS which can be used as antigens to characterize chlamydial LPS antibodies. Here we report on our results obtained with murine monoclonal antibodies and polyclonal antisera from mice, rabbits, and humans.
MATERIALS AND METHODS
Bacteria and bacterial LPS. The Re mutant of Salmonella minnesota (strain R595) was transformed with plasmid pFEN207 (17) and propagated as described previously (6) . LPS was extracted by the phenol-chloroform-petroleum ether method (14) and purified by repeated ultracentrifugation, followed by conversion to the uniform triethylammonium salt after electrodialysis (13 (22) . Synthetic antigens. The copolymerization products listed in Fig. 1 were synthesized as described previously (15, 16) . Germany, 1989; 21) . These compounds are partial structures of Re-type LPS containing the glucosamine backbone of lipid A with two amide-linked 3-hydroxymyristic acid residues and one or two KDO residues and will be abbreviated as KDOGlcNhm2 and KDO2-GlcNhm2, respectively.
Preparation of immunogens. Liposome-incorporated immunogens were prepared as previously described (3) . Heatkilled bacteria were prepared by boiling an overnight culture at 100°C for 1 h. Sheep erythrocyte (SRBC)-coated immunogens were prepared as described below by using 200 ,ug of antigen per 200 ,ul of SRBCs.
Animal antisera. Rabbit antisera against heat-killed bacteria were prepared as described previously (6) . Mouse antisera from female, 8-to 10-week-old BALB/c mice in groups of four were used. Antisera against heat-killed bacteria were prepared as described for rabbits; however, injections were done intraperitoneally. Sera against SRBC-coated and liposome-incorporated immunogens were obtained after five intraperitoneal injections of increasing amounts (20 to 50 ,ug) of antigen in a total volume of 200 ,ul of SRBCs or liposome suspension, respectively, over a 2-month period. The animals were then tested for the presence of antibodies against chlamydial LPS. The one with the highest titer was used for the preparation of monoclonal antibodies, whereas the others were given a booster 3 months later and were exsanguinated 1 Monoclonal antibodies. The following clones were obtained after immunization with purified elementary bodies of C. psittaci PK 5082 (23) (clones S5-10 and S10-3) and C. trachomatis serotype L2 (clone L21-6), serotype E (clone EVI-Hl), serotype G (clones GIII-C3 and GII-B3), and serotype F (clones FVI-A4 and FI-A6). Clones S15-1, S15-2, and S15-6 were obtained after immunization with recombinant r595-207 LPS-OH, and clone S19-3 was obtained after immunization with recombinant r595-207 LPS-HF, both Human antisera. Sera which were sent to our routineserology laboratory were collected from male and female patients with clinical symptoms of genital infections suspected to be caused by chlamydiae.
RESULTS
Characterization of murine monoclonal antibodies. Antibodies were screened for chlamydia specificity and for their ability to fix complement. Eleven antibodies were characterized further by using recombinant and chlamydial LPSs, as well as synthetic and natural partial structures from them. Table 1 shows the results. Clones EVI-Hl and FVI-A4 exhibited similar titers with all antigens tested, with differences not exceeding one dilution step. Clones S5-10 and L2I-6 gave similar results; however, they were negative with SRBCs coated with native LPS of C. psittaci. All immunoglobulin M (IgM) antibodies had significantly lower titers with native LPS compared with those against LPS-OH and LPS-HFr. Since the epitope density of a given antigen on the erythrocyte surface is influenced by its physicochemical properties (3), some antibodies were titrated against SRBCs coated with graded amounts of antigen. The results are shown in Table 2 . Clones S5-10 and L21-6 yielded the maximal titers of 128 and 64, respectively, with all three antigens. However, the amount of antigen causing a sufficient epitope density varied over a wide range. Whereas 128 ,Ig per 0.2 ml of SRBCs was required with native LPS to obtain the optimal reactivity, 16 ,ug was enough with LPS-OH, and even smaller amounts were sufficient with LPSHFr (8 and 4 ,ug for clones S5-10 and L2I-6, respectively). With clones S15-1 and S15-2, a similar pattern was observed, although at a higher level. When clone S15-1 was tested with native LPS, no activity was seen even at the highest dose of 200 jig per 0.2 ml of SRBCs. Larger amounts were not tested, since nonspecific lysis then occurred. These data suggested that the negative results shown in Table 1 did not reflect major differences in antibody specificity but, rather, affinity. Thus, the hemolytic activity of an antibody depends on the epitope density on the erythrocyte membrane, which in turn depends on the physicochemical properties of the sensitizing antigen. Therefore, we tested all antibodies against SRBCs coated with graded amounts of various LPS preparations of C. psittaci, C. trachomatis, and the recombinant strain r595-207. The results are shown in Table 3 , where the amounts of antigen yielding half-maximal titers are listed. The IgM antibodies required larger amounts of antigen than did those of the IgG type, and native LPS had (Table 4) . LPS and LPS-OH were good inhibitors for all antibodies except clone S19-3, which could not be inhibited with LPS-OH in amounts of up to 1 jig. LPS-HFr was of comparable activity, when compared with LPS-OH (the difference not exceeding one dilution step), with clones S10-3, L21-6, and S5-10; it was less active (up to two dilution steps difference) with clones EVI-Hl, GIII-C3, GII-B3, and FVI-A4. It was not active (more than two dilution steps difference) with clones S15-2, S19-3, and FI-A6. We then used synthetic antigens containing the complete KDO region of chlamydial LPS, i.e., the ot-KDO-(2---8)-x-KDO-(2->4)-a-KDO trisaccharide and mono-and disaccharide partial structures thereof for the inhibition of monoclonal antibodies. A monoclonal antibody (clone A20) recognizing a single oa-pyranosidically linked KDO (5) was included as a positive control. None of the chlamydial antibodies could be inhibited with KDO mono-or disaccharide structures in amounts of up to 25 ,ug. The KDO trisaccharide inhibited all clones except S15-2, S19-3, GIII-C3, and FI-A6 with amounts Characterization of rabbit polyclonal antisera against chiamydial LPS. IgM-and IgG-rich antisera obtained after immunization with chlamydia were titrated in the passive hemolysis assay by using chlamydial and recombinant LPSs and natural and synthetic partial structures from them. The results are shown in Table 5 . All animals had high titers against the antigens tested, those with r595-207 LPS, LPS-OH, and LPS-HFr being comparable, never differing by more than one dilution step. In addition, antibodies against Re LPS of E. coli and against the synthetic partial structures KDO-GlcNhm2 and KDO2-GlcNhm2 were observed, with significant titers. To determine whether these were due to the presence of cross-reactive or distinct antibodies, absorption experiments were performed (Table 6 ). Absorptions were not carried out successively, but separately. The activities of the respective absorbed samples against the homologous antigen could be completely abolished; however, in a few cases, two absorptions were required. After absorption with Re LPS-OH, all antisera still reacted with recombinant r595-207 LPS-OH and LPS-HFr with high titers, indicating that Re-reactive and chlamydia-reactive antibodies were present and separated from each other by absorption. Whereas the latter were specific for recombinant LPS, the former cross-reacted with recombinant LPS, by which they could be absorbed. The Re-reactive antibodies could be further divided into phosphate dependent and phosphate independent, as shown by absorption with the phosphateless synthetic partial structure KDO2-GlcNhm2, which did not result in the removal of all antibodies reacting with phosphate-containing Re LPS-OH. Phosphate dependency was also observed with chlamydia-specific antibodies. Whereas absorption with r595-207 LPS-OH abolished the reactivity towards the homologous antigen and against the dephosphorylated LPS-HFr, absorption with LPS-HFr removed only the homologous antibody and not that against LPS-OH. As expected, absorption with LPS-HFr was also unable to abolish the reactivity of phosphate-dependent Re-reactive antibodies. Re-reactive antibodies not requiring phosphate could still be represented by a variety of antibody specificities, such as those recognizing a single terminal KDO monosaccharide, a KDO disaccharide (5), or a KDO disaccharide together with parts of the glucosamine backbone of lipid A (22) . Therefore, absorption was performed with synthetic KDO-GlcNhm2 and KDO2-GlcNhm2. The results are shown in Table 7 . Absorption with KDO-GlcNhm2 resulted in the removal of the homologous reactivity and, in some cases, in the reduction or complete absorption of the reactivity directed against KDO2-GlcNhm2, indicating that KDO monosaccharide-or disaccharide-reactive antibodies were present in these antisera, with different titers. Most surprisingly, absorption with KDO2-GlcNhm2 was unable to abolish the reactivity towards KDO-GlcNhm2, although the latter represents a partial structure of the former: Therefore, these antibodies could not be specific for a KDO monosaccharide but were KDO-GlcNhm2 specific and did not cross-react with the more complex structure KDO2-GlcNhm2. Accordingly, these antibodies could not be inhibited with KDO-polyacrylamide but were inhibited with KDO-GlcNhm2 (data not shown). Such antibodies have been also detected in sera from rabbits immunized with Re bacteria (22) .
Characterization of murine polyclonal antisera against chiamydial LPS. Hyperimmune sera were prepared in mice by immunization with heat-killed bacteria and liposome-incorporated immunogens. The titers obtained in the passive hemolysis assay are listed in Table 8 . All animals had antibodies against recombinant r595-207 LPS, LPS-OH, and LPS-HFr; however, the titers varied depending on the immunogen. Highest titers were observed after immunization with LPS-OH and LPS-HF, both used as liposomeincorporated immunogens. Also, the type of the predominant antibody specificity depended on the immunization protocol. Whereas the reactivities with r595-207 LPS, LPS-OH, and LPS-HFr were comparable in sera from animals immunized with heat-killed bacteria, the others varied considerably. Most prominent were the differences in sera obtained from animals immunized with liposome-incorporated r595-207 LPS-HF. In this case, the titer against LPS was up to four dilution steps lower than that against LPS-OH or LPS-HFr. In addition, antibodies against Re LPS and the synthetic partial structure KDO2-GlcNhm2 were detected. None of the animals had titers against the synthetic antigen KDO-GlcNhm2. Again, the titers of such cross-reactive antibodies were dependent on the immunization schedule. Whereas immunization with liposome-incorporated LPS and LPS-OH yielded high titers of Re-reactive antibodies, the other immunogens did not stimulate their production. These results showed that the immune response to chlamydial LPS depends on the primary structure of the antigen on the one hand and on the physicochemical environment on the other.
Characterization of human patient antisera. Sera from patients with suspected genital chlamydial infection were tested in the passive hemolysis assay against SRBCs coated with S. minnesota r595-207 LPS-OH, r595-207 LPS-HFr, E. coli Re LPS-OH, and synthetic KDO-GlcNhm2. The correlation of titers against the two recombinant LPS was determined for 54 sera (Table 9) ; the linear correlation coefficient was 0.883, indicating that antibodies against the native and the dephosphorylated LPSs were present in comparable titers. From 54 sera, 26 did not react with E. coli Re LPS-OH and synthetic KDO-GlcNhm2. Those being positive with one of these antigens were absorbed with E. coli Re LPS-OH and retested. A representative selection of sera is shown in Table  10 . In all cases, the antibodies reacting with E. coli Re LPS-OH and synthetic KDO-GlcNhm2 were absorbed. In some sera, e.g., serum no. 36, 40, and 49, the titer against r595-207 LPS-OH was not significantly reduced, whereas in others (no. 42, 45, 46, and 56) a significant reduction by more than two dilution steps was observed. The reactivities against the dephosphorylated r595-207 LPS HFr were reduced to a comparable extent, except for serum no. 49 and 50.
DISCUSSION
The LPS and the major outer membrane protein are integral components of the cell wall of chlamydial elementary bodies and, at the same time, represent their major surface antigens. Whereas the major outer membrane protein harbors genus-, species-, and subspecies-specific epitopes, little is known about the chemical and antigenic structure of chlamydial LPS, although the latter is used as an immunochemical marker to detect chlamydiae in clinical specimens and as an antigen to detect chlamydial antibodies in patient body fluids. Chemical (1, 9, 19) and serological (1, 7, 9, 18, 21) investigations have shown that chlamydial LPS is structured in a manner similar to enterobacterial Re LPS and shares antigenic determinants with this type of LPS. In addition, it harbors a chlamydia-specific epitope which is genus specific (10) mydial LPS were described already many years ago in a phenomenological manner (11, 12) , a detailed analysis of this complex antigen on the molecular level only became amenable by the work of Nano and Caldwell (17) , who cloned a gene which coded for an enzyme (presumably a glycosyltransferase) which, when introduced into Re mutant bacteria (6) , resulted in the expression of a chlamydia-specific LPS epitope as defined by monoclonal antibodies. The availability of unlimited amounts of such recombinant LPS allowed us to determine the chemical structure of the KDO region as ao-KDO-(2-8)-ot-KDO-(2-4)-KDO (1, 16) . Based on this knowledge, we started an immunochemical investigation on the specificity of mono-and polyclonal antibodies, the results of which are reported here.
By using different immunogens (purified elementary bodies, cell walls of C. psittaci and C. trachomatis, and isolated chlamydial and recombinant LPSs), we obtained 11 monoclonal antibodies of the IgG and IgM types. The results obtained in the passive hemolysis assay in which different chlamydial and recombinant LPS preparations, as well as natural and synthetic partial structures from these sources, were used showed that none of the antibodies required the presence of ester-linked fatty acids or phosphate, since they reacted similarly with LPS-OH and LPS-HFr of S. minnesota r595-207. This also indicated that the reducing glucosamine residue was not a major component of the epitope recognized by these antibodies. However, some antibodies exhibited low reactivities with some LPS preparations, e.g., (9, 19) , whereas the latter contains fatty acids with 12 to 16 carbon atoms (2) . Therefore, the results of the hemolysis assay are understood more as a difference of these antibodies in affinity rather than in specificity. This assumption was further supported by the results of inhibition experiments, in which LPS and LPS-OH yielded similar inhibition values with all antibodies except one (clone S19-3). LPS-HFr yielded, with most of the antibodies, comparable inhibition values; however, with some antibodies, no or low inhibition was observed. Most striking were the results obtained with antibody S19-3, which could not be inhibited with LPS-OH and LPS-HFr, although it reacted with both antigens in the hemolysis assay. Since this antibody required a high epitope density and since in the inhibition assay the inhibitor competes with the SRBC-coated antigen, this behavior is attributed to a very low affinity. By using the synthetic trisaccharide ot-KDO-(2-8)-ot-KDO-(2-4)-a-KDO, the disaccharide partial structures ot-KDO-(2-8)-a-KDO and a-KDO-(2-4)-a-KDO, and KDO monosaccharide, all prepared as multivalent polyacrylamide copolymerization products, none of the antibodies could be inhibited with any of the partial structures. The KDO trisaccharide inhibited 6 out of 11 antibodies; however, the values, compared with those of a KDO monosaccharidespecific antibody, were 1 order of magnitude lower. At present it is difficult to decide whether these data should be taken as an indication that the KDO trisaccharide alone is not the complete epitope recognized by these antibodies or whether the epitope is not accessible to the antibody due to conformational changes in the copolymerization product. Our current investigations on the conformation of the KDO trisaccharide linked to glucosamine (as in LPS) or to the polyacrylamide chain indicate that the ligand may not be freely accessible to antibodies in the latter. However, the KDO monosaccharide-specific antibody can react with the terminal KDO residue, being separated from the acrylamide chain by two KDO residues. In summary, the data show that all antibodies tested recognize closely related epitopes requiring the presence of three KDO residues in a defined linkage (since they do not react with Re and other LPS) and that they do not require the presence of phosphoryl or ester-linked acyl groups or the reducing glucosamine residue of lipid A. The role of amide-linked fatty acids and the KDO proximal glucosamine remains to be elucidated. At least for some antibodies, amide-linked fatty acids are also dispensable, since they bound to completely deacylated LPS coupled to Sepharose (data not shown).
On the basis of these results and those reported on monoclonal and polyclonal antibodies against Re LPS (22), we tried to dissect different antibody specificities present in polyclonal antisera of rabbits, mice, and humans. In this part of the study, we showed that rabbit antisera against chlamydiae contained chlamydia-specific antibodies and those cross-reacting with Re LPSs, which could be separated from each other by absorption with defined antigens. (Note: the term cross-reaction is used in the following in a descriptive way rather than as an immunochemical term. We do not know at present whether Re-reactive antibodies react with the Re portion of chlamydial LPS or whether chlamydial LPS is heterogeneous and contains a population of LPSs with only two KDO residues. The answer to this question will be given when chemically homogeneous LPSs or partial structures thereof have been synthesized or prepared from natural sources). By using natural and synthetic partial structures of recombinant and Re LPSs, it was found that among both, the chlamydia-specific and the Re-reactive antibodies, those requiring phosphate groups and those for which the presence of phosphate was dispensable were present. The results also showed that the Re-reactive ones could be absorbed without affecting the chlamydia-specific antibodies. Whereas chlamydia-specific and Re-reactive antibodies were present in comparable titers in rabbit antisera, mouse antisera contained predominantly chlamydia-specific antibodies. Here, the immunization protocol had a strong influence on the titer and the ratio of these two types of antibodies. Particularly high titers were obtained after immunization with dephosphorylated LPS incorporated into liposomes.
The cross-reactivity of chlamydial antisera with Re LPS is one of the disadvantages from which routine chlamydial serology with patient sera suffers, since a positive reaction with chlamydial LPS is obtained with chlamydia-specific and Re-reactive antibodies. Since the latter may arise from contact with chlamydial, Re-type LPS, or any other LPS, the results are difficult to interpret. Different serological assays do not overcome this general problem as long as the antigen is LPS. Therefore, we also looked for antibody specificities present in human sera from patients suspected to have a genital chlamydial infection. Although we have studied only a small number of sera (n = 54), it is evident that chlamydia-specific and Re-reactive antibodies occur also in human sera and, as shown for rabbit antisera, are dependent or not dependent on the presence of phosphate groups. Absorption experiments with some sera showed that the ratio of the different specificities to each other varied considerably. At present, we are carrying out studies on sera from clinically defined chlamydial infections which may allow us in the future to assign a certain type or stage of chlamydial disease to distinct reactivity patterns, with a selection of antigens to be defined. expert technical assistance of S. Werner, U. Albert, and V. Susott is gratefully acknowledged. We thank M. Grunefeld and E. Brandt for their help in establishing the hybridoma technology.
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